| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213453 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 36 Pages |
Abstract
Patients with vulvar squamous cell carcinoma and positive surgical margins derive an OS benefit from aRT with a seemingly optimal dose in the range of 54.0 to 59.9Â Gy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bhavana V. MD, Beant S. MD, Akila N. MD, MPH, Goundappa K. PhD, Paniti MD, Sushil MD,